GSK plc
NYSE:GSK

  • LAST PRICE
    33.3500
  • TODAY'S CHANGE (%)
    -1.0400 (-3.0241%)
  • Bid / Lots
    33.0000/ 1
  • Ask / Lots
    33.3500/ 10
  • Open / Previous Close
    33.2600 / 34.3900
  • Day Range
    32.8250
    33.5000
  • 52 Week Range
    32.8250
    45.9250
  • Volume
    13,747,891

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Pharmaceuticals - Diversified Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
GSK
GSK plc
68.3B
21.7x
+6.39%
BMY
Bristol-Myers Squibb Co
114.0B
-15.6x
+4.90%
SNY
Sanofi SA
122.0B
25.3x
+4.55%
BAYRY
Bayer AG
21.0B
-22.7x
---
PFE
Pfizer Inc
140.5B
33.3x
-7.10%
AZN
AstraZeneca PLC
195.9B
30.4x
+17.52%
As of 2024-11-16

Company Information

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases. It is advancing oligonucleotide therapeutics in chronic hepatitis B and steatotic liver disease as well as other therapeutic areas beyond liver disease.

Contact Information

Headquarters
980 Great West RoadBRENTFORD, United Kingdom TW8 9GS
Phone
208-047-5000
Fax
208-047-7807

Executives

Independent Non-Executive Chairman of the Board
Jonathan Symonds
Chief Executive Officer, Executive Director
Emma Walmsley
Chief Financial Officer, Executive Director
Julie Brown
President - Corporate Development
David Redfern
President - Global Supply Chain
Regis Simard

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$68.3B
Revenue (TTM)
$39.5B
Shares Outstanding
2.1B
Dividend Yield
4.71%
Annual Dividend Rate
1.5711 USD
Ex-Dividend Date
11-15-24
Pay Date
01-09-25
Beta
0.66
EPS
$1.54
Book Value
$8.30
P/E Ratio
21.7x
Price/Sales (TTM)
1.7
Price/Cash Flow (TTM)
9.6x
Operating Margin
12.45%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.